Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed a significant capital injection of RMB493.6 million into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. This move, involving the transfer of full equity interest in Tianjin Zhongxin Medicine Co., Ltd., aims to strengthen its position in the pharmaceutical sector. The completion follows the resolutions passed during the company’s board meeting and subsequent approvals.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Keep On Buying,’ Says Investor About Microsoft Stock
- ‘Priced for Fantasy,’ Says Investor About Tesla Stock
- ‘Remain Skeptical,’ Says Top Investor About AMD Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
